Behavioural and clinical predictors for Loiasis

Journal of Global Health
Johannes MischlingerMichael Ramharter

Abstract

Loiasis is a vector-borne disease in Central and West Africa. While there is still uncertainty to what extent loiasis is responsible for population morbidity, individuals having both loiasis and onchocerciasis have a high risk of fatal encephalopathy when treatment (ie, ivermectin) for onchocerciasis is given. Therefore it is current policy that communities of high loiasis-burden are excluded from mass drug administration programmes of ivermectin. To address this treatment gap we present diagnostic scores, based on clinical and behavioural predictors that may help to rapidly identify sub-groups with loiasis within high-burden communities. A cross-sectional survey was performed in the province of la Ngounie, Gabon between December 2015 and Februrary 2016 and 947 participants of all ages were recruited. Clinical parameters and behavioural exposure factors were ascertained by questionnaire-based interviews. Parasitological analysis of blood samples was performed for L. loa detection. Diagnostic scores consisting of clinical and behavioural factors were modelled to predict loiasis in sub-groups residing in endemic regions. Increasing sylvan exposure was identified as important risk factor for loiasis with adjusted odds ratios of 5....Continue Reading

References

Oct 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R M RakitaM A Kielhofner
Sep 1, 1996·The Journal of Infection·D R ChurchillR N Davidson
Oct 31, 2003·Transactions of the Royal Society of Tropical Medicine and Hygiene·Samuel WanjiPeter Enyong
Oct 1, 1988·Parasitology Today·M Pinder
Jan 18, 2007·Annals of Tropical Medicine and Parasitology·M Boussinesq
Feb 24, 2007·Annals of Tropical Medicine and Parasitology·I TakougangM Ntep
Jan 1, 2007·Wiener klinische Wochenschrift·Michael RamharterPeter G Kremsner
Nov 27, 2007·Bulletin of the World Health Organization·Erik von ElmUNKNOWN STROBE Initiative
May 10, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Jeannie J Padgett, Kathryn H Jacobsen
Jul 5, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A HoeraufS Specht
Oct 25, 2011·PLoS Neglected Tropical Diseases·Jean Paul AkueEric Maurice Leroy
Jun 30, 2012·PLoS Neglected Tropical Diseases·Louise A Kelly-HopeDavid H Molyneux
Jul 13, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Spinello AntinoriMario Corbellino
Sep 17, 2013·Travel Medicine and Infectious Disease·Natacha GantoisFabrice Simon
Dec 18, 2013·The Lancet Infectious Diseases·Wolfram Gottfried Metzger, Benjamin Mordmüller
Oct 29, 2015·Radiology·Patrick M BossuytUNKNOWN STARD Group
Apr 28, 2017·Wiener klinische Wochenschrift·Johannes Mischlinger, Eva Schernhammer

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
light microscopy

Software Mentioned

RAPLOA
Stata

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

Transactions of the Royal Society of Tropical Medicine and Hygiene
J P ChippauxN Barberi
Lancet
Cornelus J G Sanders, Christian A J J Jaspers
© 2022 Meta ULC. All rights reserved